New study reveals alarming cardiovascular risks from COVID
Can't see this email? View it online
   
  COVID-19  
  The latest COVID-19 news from News Medical  
 Is long COVID triggering irritable bowel syndrome? Arizona study to investigateIs long COVID triggering irritable bowel syndrome? Arizona study to investigate
 
The Arizona CoVHORT research study at the University of Arizona has received $3.2 million in funding to investigate the links between long COVID and gastrointestinal symptoms, specifically irritable bowel syndrome (IBS). Led by epidemiologist Kristen Pogreba-Brown, the study aims to determine how COVID-19 impacts the incidence of IBS, offering potential benefits to millions affected by the ongoing pandemic.
 
 
 New study reveals alarming cardiovascular risks from COVIDNew study reveals alarming cardiovascular risks from COVID
 
The study published in Nature Cardiovascular Research reveals that SARS-CoV-2, the virus causing COVID-19, can directly infect coronary vessels and arterial plaques, heightening the risk of cardiovascular complications like heart attacks and strokes. These findings offer critical insights into the increased long-term cardiovascular risks for COVID-19 survivors and open new avenues for targeted therapies.
 
   Primate model unlocks clues to long-COVID's impact on blood sugar, hints at vaccine benefitsPrimate model unlocks clues to long-COVID's impact on blood sugar, hints at vaccine benefits
 
The study uses a non-human primate model to explore the link between long-COVID and disruptions in glucose metabolism, finding a positive correlation. Vaccination appeared to improve glycemic control, suggesting a possible role in managing long-COVID symptoms.
 
   Medication and mutations: molnupiravir's impact on SARS-CoV-2 genomesMedication and mutations: molnupiravir's impact on SARS-CoV-2 genomes
 
Researchers discovered molnupiravir-associated mutational signatures in SARS-CoV-2 genomes.
 
   Ginger shows promise as a natural defense against autoimmune diseasesGinger shows promise as a natural defense against autoimmune diseases
 
Comprehensive study reveals that whole ginger extracts have a significant impact on inhibiting neutrophil hyperactivity, a key factor in autoimmune diseases like APS and lupus. Consuming ginger for just a week showed promising results in both animal models and human trials, positioning it as a natural and affordable treatment option for a range of autoimmune disorders.
 
 Long COVID unmasked: Patients share varied physical, mental, and social challenges
 
Long COVID unmasked: Patients share varied physical, mental, and social challengesPatient experiences of the post-acute sequelae of coronavirus disease 2019 (COVID-19) or long COVID.
 
 
 Long COVID's biological blueprint: new study offers promising insights
 
Long COVID's biological blueprint: new study offers promising insightsResearchers designed a cross-sectional study to investigate the biological underpinnings of “Long COVID”, the post-acute infection syndrome triggered by SARS-CoV-2.
 
 
 SARS-CoV-2 infects coronary vessels, inducing plaque inflammation
 
SARS-CoV-2 infects coronary vessels, inducing plaque inflammationSARS-CoV-2, the virus that causes COVID-19, can directly infect the arteries of the heart and cause the fatty plaque inside arteries to become highly inflamed, increasing the risk of heart attack and stroke, according to a study funded by the National Institutes of Health.
 
 
 New study reveals BA.2.86 subvariant's surprising dance with antibodies
 
New study reveals BA.2.86 subvariant's surprising dance with antibodiesResearchers examined the antigenicity of the emerging SARS-CoV-2 subvariant BA.2.86, finding that it is not resistant to neutralizing antibodies from previously infected or vaccinated individuals, although it does show increased binding affinity to the ACE-2 receptor. The study highlights the subvariant's sensitivity and resistance to different classes of monoclonal antibodies, offering insights for future treatment and vaccine development.
 
 
 New material more efficient at capturing coronavirus proteins with minimal impact on breathability
 
New material more efficient at capturing coronavirus proteins with minimal impact on breathabilityA research team at the University of Liverpool has developed a new material that captures coronavirus particles and could transform the efficiency of face masks and other filter equipment to stop the spread of COVID-19 and other viruses.
 
 
 US health care workers are at greater risk of suicide than non–health care workers
 
US health care workers are at greater risk of suicide than non–health care workersThe risks of death by suicide for six healthcare worker (HCW).
 
 
 Research shines light on the profound effect of Long Covid on the lives of children and young people
 
Research shines light on the profound effect of Long Covid on the lives of children and young peopleNew research from the Nuffield Department of Primary Care Health Sciences, the University of Oxford, and the universities of Stirling and Aberdeen funded by the National Institute for Health and Care Research (NIHR), has shone a spotlight on the profound effect Long Covid can have on children and young people's school experience and wider lives.
 
 
 Brigham researchers quantify the burden of SARS-CoV-2-associated sepsis
 
Brigham researchers quantify the burden of SARS-CoV-2-associated sepsisUsing data from Mass General Brigham's electronic health records, Brigham researchers quantified the burden of SARS-CoV-2-associated sepsis early in the pandemic.
 
 
 Could baseline gut microbiota predict the immune responses elicited by COVID-19 vaccines?
 
Could baseline gut microbiota predict the immune responses elicited by COVID-19 vaccines?Researchers characterized the gut microbiota composition associated with the durability of COVID-19 vaccine-induced immunity.
 
 
 Aerosolized ACE2 neutralizes COVID-19 variants in lab and mice tests
 
Aerosolized ACE2 neutralizes COVID-19 variants in lab and mice testsResearchers from the University of Texas Southwestern have developed an aerosolized, mutated form of ACE2 that effectively neutralizes various SARS-CoV-2 variants in both cell cultures and mice. The study suggests that this modified ACE2 has promising preventive and therapeutic potential against COVID-19, especially with its easy aerosolized administration.
 
 
 Vaxzevria vaccine boosts mucosal immunity in COVID-19 recovered
 
Vaxzevria vaccine boosts mucosal immunity in COVID-19 recoveredStudy highlights the ability of the Vaxzevria vaccine in inducing robust mucosal antibody responses, especially in COVID-19-recovered individuals, showcasing a notable defense against various SARS-CoV-2 variants. However, it emphasizes the need for booster doses to enhance anti-SARS-CoV-2 mucosal immunity, especially in infection-naïve individuals, to broaden protection against emerging viral variants.
 
 
 How lifestyle tweaks could be the new shield against memory loss: U.S. POINTER study dives in
 
How lifestyle tweaks could be the new shield against memory loss: U.S. POINTER study dives inThe U.S. POINTER study aims to explore if lifestyle changes like exercise, diet, and social activities can help preserve cognitive function in older Americans at risk for dementia. Modeled after Finland's successful FINGER study and set to complete in 2025, this extensive research will involve 2,000 participants and focus on diverse and culturally informed strategies.
 
 
 Can training to suppress thoughts improve mental health? Study challenges century-old wisdom
 
Can training to suppress thoughts improve mental health? Study challenges century-old wisdomResearchers describe the effects of thought suppression on mnemonic, affective, positive, or negative mental health indices.
 
 
 As covid infections rise, nursing homes are still waiting for vaccines
 
As covid infections rise, nursing homes are still waiting for vaccines"Covid is not pretty in a nursing home," said Deb Wityk, a 70-year-old retired massage therapist who lives in one called Spurgeon Manor, in rural Iowa. She twice contracted the disease and is eager to get the newly approved vaccine because she has chronic lymphocytic leukemia, which weakens her immune system.
 
 
 Commonly used anti-viral drugs reduce risk of hospitalization, death in patients with mild COVID-19
 
Commonly used anti-viral drugs reduce risk of hospitalization, death in patients with mild COVID-19New Cleveland Clinic-led research shows commonly used COVID-19 anti-viral drugs Paxlovid (nirmatrelvir) and Lagevrio (molnupiravir) reduce risk of hospitalization and death in high-risk patients with mild disease, even with Omicron subvariants.